Search our news archive and pharma companies…
|
Today's News | Note: News feeds may no longer be available for the articles on this page.
Pfizer,
Takeda to promote diabetes drug in China 11:49 AM 12/15/2009
Reuters
The agreement allows Takeda to increase the number of medical representatives in the
sales and marketing of its Actos product using the territory coverage of Pfizer in China.
...
Make-or-break
decision looms for Ark's cancer drug 8:01 AM 12/15/2009
Reuters
European approval for Ark Therapeutics' Cerepro is key to the company's future.
Cerepro is an unusual gene-based drug for brain cancer. Many doubt its chances.
...
Crucell
may add polio to protect vaccine sales 4:58 AM 12/15/2009
Reuters
Crucell NV will likely look to add a sixth antigen to its Quinvaxem vaccine as part of
expected product add-ons after a stake sale to Johnson & Johnson.
...
Gilead
heart drug disappoints, program likely dropped 5:34 PM 12/14/2009
Reuters
Gilead Sciences Inc reported its experimental blood pressure drug
Darusentan failed to meet its primary goals in a late-stage study.
...
Addex
stops lead drug trial due to liver problems 12:45 PM 12/14/2009
Reuters
Addex stopped a mid-stage trial of its lead drug candidate ADX10059
against migraine due to liver problems. ADX10059 recently hit its main target in a separate Phase IIb trial
against heartburn.
...
US
FDA staff: Tarceva effective for wider use 10:09 AM 12/14/2009
Reuters
Tarceva met the main goals in a study testing effectiveness when given to lung
cancer patients immediately after chemotherapy. It's co-marketed by Roche Holding and OSI Pharmaceuticals.
...
Swiss
eye drug maker Alcon acquires Optonol Ltd. 8:08 AM 12/14/2009
The Associated Press
Alcon will buy Optonol Ltd to gain the Ex-Press Mini
Glaucoma Shunt which lowers intraocular pressure in glaucoma patients.
...
Drug
importation: bad for our health 6:46 AM 12/14/2009
Baltimore Sun
A democrat senator from North Dakota describes prescription drugs as cheap
commodities that should be readily available without regard to appropriate use.
...
Roche,
Immunogen 'Guided Missile' Targets Tumors 1:21 PM 12/12/2009
Bloomberg
T-DM1 combines Roche’s Herceptin (trastuzumab) with a potent cancer-killing drug
developed by Immunogen. It shrank the tumors of one-third of the critically ill advanced breast cancer
patients.
...
Nexavar
may help breast cancer drugs work longer 5:06 AM 12/12/2009
Reuters
US researchers say Nexavar (sorafenib) from Bayer and development partner
Onyx Pharmaceuticals helped re-sensitize breast cancer to treatment with aromatase inhibitors.
...
Experimental
drug kills breast cancer stem cells 5:03 PM 12/11/2009
Reuters
Studies in animals and women with advanced breast cancer showed that Merck & Co's
experimental compound MK-0752 killed off cancer stem cells that linger in the breast after chemotherapy.
...
Sanofi
breast cancer drug gets FDA fast-track nod 3:33 PM 12/11/2009
Reuters
Sanofi-Aventis said the US FDA will review its BSI-201 experimental
breast cancer drug on an accelerated basis. The agency will accept initial late-stage data instead of waiting
for entire Phase III clinical trial results.
...
Biotech
giant drops Seattle Genetics drug program 9:29 AM 12/11/2009
Seattle Times
Genentech will terminate collaboration with Seattle Genetics ending a deal that
could have yielded over $800 million for development and commercialization of dacetuzumab for non-Hodgkin
lymphoma and multiple myeloma.
...
Pfizer
wins Europe approval for new vaccine 7:02 AM 12/11/2009
Reuters
Pfizer Inc won European approval for a more protective form of its blockbuster vaccine
Prevenar 13 that fights pneumonia. Known as Prevnar in the US, the vaccine prevents infections among infants
and children.
...
WHO
backs findings on Tamiflu for seasonal flu 6:18 AM 12/11/2009
Reuters
The World Health Organization agrees there is no evidence that antiviral Tamiflu
prevents complications in healthy people with seasonal flu. WHO continues to recommend the drug for H1N1 swine
flu virus who are at high risk.
...
<- Day Earlier | Today's News
|
